Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| DNA Nucleotidyltransferases | 1 | 1995 | 175 | 0.120 |
Why?
|
| Antigens, Nuclear | 1 | 1995 | 184 | 0.120 |
Why?
|
| Mice, SCID | 2 | 1995 | 2621 | 0.100 |
Why?
|
| DNA Helicases | 1 | 1995 | 850 | 0.090 |
Why?
|
| Gene Rearrangement | 1 | 1994 | 1125 | 0.080 |
Why?
|
| Transcription, Genetic | 1 | 2001 | 7571 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2001 | 5300 | 0.070 |
Why?
|
| DNA Repair | 1 | 1995 | 2041 | 0.070 |
Why?
|
| DNA | 2 | 1995 | 7189 | 0.060 |
Why?
|
| RNA, Neoplasm | 2 | 2001 | 748 | 0.050 |
Why?
|
| Proto-Oncogenes | 1 | 2001 | 321 | 0.050 |
Why?
|
| Leukemia-Lymphoma, Adult T-Cell | 1 | 2002 | 164 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2002 | 3777 | 0.040 |
Why?
|
| Gene Expression Regulation, Leukemic | 1 | 2001 | 651 | 0.040 |
Why?
|
| Translocation, Genetic | 1 | 2001 | 1391 | 0.030 |
Why?
|
| VDJ Recombinases | 1 | 1995 | 84 | 0.030 |
Why?
|
| Consensus Sequence | 1 | 1995 | 362 | 0.030 |
Why?
|
| Exodeoxyribonuclease V | 1 | 1994 | 8 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1995 | 452 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2001 | 6124 | 0.030 |
Why?
|
| DNA-Binding Proteins | 3 | 2002 | 9566 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1994 | 775 | 0.030 |
Why?
|
| Gene Expression Profiling | 4 | 2002 | 9416 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 849 | 0.030 |
Why?
|
| Exodeoxyribonucleases | 1 | 1994 | 191 | 0.030 |
Why?
|
| Neoplasm Proteins | 2 | 2002 | 3594 | 0.030 |
Why?
|
| CHO Cells | 1 | 1995 | 1379 | 0.030 |
Why?
|
| 3T3 Cells | 1 | 1994 | 1083 | 0.030 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2001 | 1549 | 0.030 |
Why?
|
| Neoplasms | 1 | 2001 | 22140 | 0.030 |
Why?
|
| Transcription Factors | 2 | 2002 | 12099 | 0.020 |
Why?
|
| Cricetinae | 1 | 1995 | 2412 | 0.020 |
Why?
|
| Nucleic Acid Conformation | 1 | 1994 | 896 | 0.020 |
Why?
|
| Clone Cells | 1 | 1994 | 1668 | 0.020 |
Why?
|
| RNA, Messenger | 2 | 2001 | 12747 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2002 | 4513 | 0.020 |
Why?
|
| Recombination, Genetic | 1 | 1994 | 1518 | 0.020 |
Why?
|
| HeLa Cells | 1 | 1995 | 3073 | 0.020 |
Why?
|
| Gene Expression | 1 | 2001 | 7571 | 0.020 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1988 | 244 | 0.020 |
Why?
|
| Transfection | 1 | 1994 | 5748 | 0.020 |
Why?
|
| Growth Hormone | 1 | 1988 | 569 | 0.020 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1988 | 413 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15308 | 0.020 |
Why?
|
| Base Sequence | 1 | 1995 | 12404 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 2001 | 6341 | 0.010 |
Why?
|
| Isoenzymes | 1 | 1988 | 1682 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 1995 | 17598 | 0.010 |
Why?
|
| Homeodomain Proteins | 2 | 2002 | 2414 | 0.010 |
Why?
|
| Metalloproteins | 1 | 2002 | 97 | 0.010 |
Why?
|
| B-Lymphocytes | 1 | 1994 | 4744 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 1995 | 5782 | 0.010 |
Why?
|
| Genes, Homeobox | 1 | 2001 | 285 | 0.010 |
Why?
|
| Cell Line | 1 | 1994 | 15545 | 0.010 |
Why?
|
| Carcinoma, Small Cell | 1 | 2001 | 420 | 0.010 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2001 | 305 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 2001 | 693 | 0.010 |
Why?
|
| Mice | 2 | 1995 | 81326 | 0.010 |
Why?
|
| Oncogene Proteins | 1 | 2002 | 718 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2002 | 1607 | 0.010 |
Why?
|
| Survival Rate | 2 | 2002 | 12728 | 0.010 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2001 | 682 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2001 | 13385 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1867 | 0.010 |
Why?
|
| T-Lymphocytes | 1 | 1994 | 10203 | 0.010 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2002 | 1132 | 0.010 |
Why?
|
| Animals | 3 | 1995 | 168079 | 0.010 |
Why?
|
| Neoplastic Stem Cells | 1 | 2001 | 1348 | 0.010 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2001 | 1605 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2001 | 2548 | 0.010 |
Why?
|
| Liver | 1 | 1988 | 7514 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 2820 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2002 | 2897 | 0.010 |
Why?
|
| Acute Disease | 1 | 2001 | 7226 | 0.010 |
Why?
|
| Neoplasm Metastasis | 1 | 2001 | 4909 | 0.010 |
Why?
|
| Humans | 5 | 2002 | 761208 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2001 | 3388 | 0.010 |
Why?
|
| Steroid Hydroxylases | 1 | 1988 | 93 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1988 | 819 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2001 | 4021 | 0.000 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1988 | 1728 | 0.000 |
Why?
|
| Smoking | 1 | 2001 | 9055 | 0.000 |
Why?
|
| Disease Progression | 1 | 2001 | 13511 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2002 | 11509 | 0.000 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 1988 | 3803 | 0.000 |
Why?
|
| Time Factors | 1 | 2001 | 39957 | 0.000 |
Why?
|
| Infant | 1 | 2002 | 36169 | 0.000 |
Why?
|
| Child, Preschool | 1 | 2002 | 42224 | 0.000 |
Why?
|
| Sex Characteristics | 1 | 1988 | 2640 | 0.000 |
Why?
|
| Child | 1 | 2002 | 80152 | 0.000 |
Why?
|
| Adolescent | 1 | 2002 | 88298 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2001 | 80674 | 0.000 |
Why?
|
| Rats | 1 | 1988 | 23704 | 0.000 |
Why?
|
| Male | 2 | 2002 | 360693 | 0.000 |
Why?
|
| Female | 2 | 2002 | 392544 | 0.000 |
Why?
|
Concepts
(96)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_